PGR and ductal breast carcinoma in situ: Biopsy and histopathological examination showed an estrogen receptor (ER)-positive (90%), progesterone receptor (PR)-positive (90%), HER2 receptor-negative (0%), and Ki67-positive (45%) G3 ductal carcinoma in situ (DCIS).